- Home
- ELBM vs CRIS Comparison
ELBM vs CRIS Comparison
Compare ELBM & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELBM
- CRIS
- Stock Information
- Founded
- ELBM 2011
- CRIS 2000
- Country
- ELBM Canada
- CRIS United States
- Employees
- ELBM N/A
- CRIS N/A
- Industry
- ELBM Industrial Machinery/Components
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ELBM Miscellaneous
- CRIS Health Care
- Exchange
- ELBM Nasdaq
- CRIS Nasdaq
- Market Cap
- ELBM 19.2M
- CRIS 22.9M
- IPO Year
- ELBM N/A
- CRIS 2000
- Fundamental
- Price
- ELBM $1.64
- CRIS $1.59
- Analyst Decision
- ELBM Strong Buy
- CRIS Strong Buy
- Analyst Count
- ELBM 2
- CRIS 2
- Target Price
- ELBM $2.20
- CRIS $16.50
- AVG Volume (30 Days)
- ELBM 20.5M
- CRIS 69.9K
- Earning Date
- ELBM 11-14-2025
- CRIS 11-13-2025
- Dividend Yield
- ELBM N/A
- CRIS N/A
- EPS Growth
- ELBM N/A
- CRIS N/A
- EPS
- ELBM N/A
- CRIS N/A
- Revenue
- ELBM N/A
- CRIS $11,405,000.00
- Revenue This Year
- ELBM N/A
- CRIS $2.72
- Revenue Next Year
- ELBM N/A
- CRIS $8.27
- P/E Ratio
- ELBM N/A
- CRIS N/A
- Revenue Growth
- ELBM N/A
- CRIS 12.24
- 52 Week Low
- ELBM $0.77
- CRIS $1.02
- 52 Week High
- ELBM $8.70
- CRIS $5.45
- Technical
- Relative Strength Index (RSI)
- ELBM 48.65
- CRIS 46.46
- Support Level
- ELBM $1.60
- CRIS $1.44
- Resistance Level
- ELBM $2.64
- CRIS $1.63
- Average True Range (ATR)
- ELBM 1.06
- CRIS 0.10
- MACD
- ELBM -0.09
- CRIS 0.00
- Stochastic Oscillator
- ELBM 7.34
- CRIS 46.13
About ELBM Electra Battery Materials Corporation
Electra Battery Materials Corp is building North America's fully integrated, localized, and environmentally sustainable battery materials park. Electra Battery Materials is an integral part of the North American battery supply chain, providing low-carbon, sustainable, and traceable raw materials for the region's fast growing electric vehicle industry.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.